A5017750641- COVID-19 Clinical Research Studies
- Renal Diseases and Glomerulopathies
- Renal Transplantation Outcomes and Treatments
- Nephrotoxicity and Medicinal Plants
- COVID-19 and healthcare impacts
- Sepsis Diagnosis and Treatment
- Immunotherapy and Immune Responses
- Migraine and Headache Studies
- Neuroendocrine Tumor Research Advances
- Aortic Thrombus and Embolism
- Cytokine Signaling Pathways and Interactions
- Digestive system and related health
- Complement system in diseases
- Bipolar Disorder and Treatment
- Myofascial pain diagnosis and treatment
- Methemoglobinemia and Tumor Lysis Syndrome
- Polyomavirus and related diseases
- Botulinum Toxin and Related Neurological Disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Biliary and Gastrointestinal Fistulas
- SARS-CoV-2 and COVID-19 Research
- Advanced Glycation End Products research
- Testicular diseases and treatments
- Neurological and metabolic disorders
- Blood Coagulation and Thrombosis Mechanisms
Universitätsklinikum Würzburg
2017-2024
University of Würzburg
2008-2021
Aschaffenburg University of Applied Sciences
2021
Innsbruck Medical University
2020
Heidelberg University
1989
Abstract Introduction Evidence from a number of open-label, uncontrolled studies has suggested that rituximab may benefit patients with autoimmune diseases who are refractory to standard-of-care. The objective this study was evaluate the safety and clinical outcomes in several standard-of-care-refractory (within rheumatology, nephrology, dermatology neurology) other than rheumatoid arthritis or non-Hodgkin's lymphoma real-life setting. Methods Patients received having shown an inadequate...
Abstract Background Several clinical trials have shown beneficial effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on kidney disease progression and cardiovascular morbidity mortality in patients with chronic (CKD) without type diabetes mellitus. However, some subgroups CKD been excluded from participation these trials, such as severely impaired function, dialysis, transplant recipients. Methods The Renal Lifecycle trial (NCT05374291) is a pragmatic, international, multicenter,...
Healthcare workers (HCWs) are recommended to receive at least three spike-antigen exposures generate basic immunity and mediate herd protection of vulnerable patients. So far, less attention has been put on the cellular immune response induced by homologous (three BTN162b2mRNA doses) or heterologous (mRNA-1273 as third dose building two BTN162bmRNA immunological impact breakthrough infections (BTIs). Therefore, in 356 vaccinated HCWs with without BTIs Anti-SARS-CoV-2-Spike-IgG concentrations...
Many reports document a variety of neurological complications resulting from both intravenous and intrathecal administration methotrexate, but acute cerebral oedema is not among them.We describe patient with myeloid leukaemia who developed after treatment methotrexate.A 23 year old Jamaican woman was admitted diagnosis pnyeloid (M3).
Continuous glucose monitoring (CGM) improves treatment with lower blood levels and less patient effort. In combination continuous insulin application, glycemic control hypoglycemic episodes should decrease. Direct feedback of CGM to subcutaneous using an algorithm is called a closed-loop (CL) artificial pancreas system. Commercial devices stop application by predicting through direct interaction between the sensor pump. The prediction usually made for about 30 minutes delivery restarted at...
Abstract Cholesterol embolization or atheroembolic renal disease (AERD) is an often underdiagnosed issue in patients featuring a prevalent risk profile. It multisystemic with progressive insufficiency due to foreign body reaction of cholesterol crystals flushed into small vessel system the kidneys from arteriosclerotic plaques. The most common setting which it occurs iatrogenic after vascular catheterization and less frequent spontaneously. Typical clinical symptoms are delayed impairment...
The prevalence of cardiovascular disease is high among patients with chronic kidney and events (CVE) remain the leading cause death after transplantation (KT). We performed a retrospective analysis 389 KT recipients to assess if European Society Cardiology Score (ESC-Score), Framingham Heart Study (FRAMINGHAM), Prospective Cardiovascular Munster (PROCAM-Score) or Assessing risk using Scottish Intercollegiate Guidelines Network (ASSIGN-Score) algorithms can predict at time entering waiting list.
There is evidence that SARS-CoV2 has a particular affinity for kidney tissue and often associated with failure.
Abstract Introduction There is evidence that SARS-CoV2 has a particular affinity for kidney tissue and often associated with failure. Methods We assessed whether proteinuria can be predictive of failure, the development chronic disease, mortality in 37 critically ill COVID-19 patients. used machine learning (ML) methods as decision trees cut-off points created by OneR package to add new aspects, even smaller cohorts. Results Among total patients, 24 suffered higher-grade renal 20 whom...
Patienten mit chronischer Niereninsuffizienz zeigen häufig atypische Symptome für eine kardiovaskuläre Problematik. Die richtige Interpretation der Symptomatik ist ausschlaggebend, um das Risiko einen herzbedingten Notfall richtig einzuschätzen und präventive Maßnahmen zu ergreifen die Therapie einzuleiten.